Congrats to ALBAN and POTOMAC #ESMO25. Super fun to compare all three PD1-BCG papers with @tompowles1. Clear differences in trial design may explain different outcomes.

🚨PUBLICATION ALERT🚨 Genomic Signatures Correlating With Adverse Pathologic Features in Men Eligible for Active Surveillance Authors included: Jamie Michael, MD, Eric Li, MD, Mitch Huang, MD, Nicole Handa, MD, Hiten Patel, MD, MPH, Ridwan Alam, MD, Edward Schaeffer, MD, PhD,

How fast do #rcc tumor thrombi grow? 📈 In our cohort @MayoUrology (n=141), venous tumor thrombi expanded ~1 cm/month (wide range). Faster growth seen with higher Mayo level, sarcomatoid/rhabdoid features & metastasis. These data can guide pre-op imaging & surgical triage.

https://t.co/DTd5m80LM8 Great work from the ENACT study team with to examine enzalutamide transcriptional effects @ashleyrossmdphd @AstellasUS

Congratulations Nir Tomer, MD on being the next Northwestern Endourology Fellow for the 2026-2027 Academic year. It is going to be an amazing year! @NM_Urology @EndourologyNm

🔧✨ Breaking news! We’re thrilled to welcome our newest GURS fellow, Emily Ji, MD! Congratulations —we can’t wait to see you restore form & function while making a lasting impact in urology! 👏✨ @societygurs @amerurological

Nice work from @NM_Urology team https://t.co/k3xdU5uVxZ

🚨Can the transcriptome reveal therapeutic vulnerabilities in localized #prostatecancer?🚨 👉Check out our analysis of >140k tumor samples in @EurUrolOncol 🔗 https://t.co/Kxvhh5JXuI

A lot of talk about patients with borderline renal function (GFR of 40-60 ml/min) that are ? cis-eligible. Here, we present the outcomes of patients from Niagara, showing consistent improvement in EFS and pCR. #AUA2025

Congratulations to the newly awarded 2025 National Residency Abstract Olympics winners! 🏆 @NM_Urology @wiscurology @WCMUrology #AUA25

Congratulations to our hardworking residents for winning 🥇at the National residents abstract Olympics!! @HitenDPatel @evan_panken @Jamie_A_Michael @c_arruzafrau @NM_Urology @NellieB_Uro @EdwardSchaeffer

Great to see our JU paper making it into the NMIBC instructional course! TURBT quality is important! And modifiable! #AUA25 @Uro_Rich @JoshMeeks

Congratulations to resident physician, Mitchell Huang, MD, who took second place for his presentation on prostate MRI utilization for Rural Veterans at the Urological Society for American Veterans meeting! 🥈 #AUA25 @AmerUrological

Joshua Meeks, MD, PhD (@joshmeeks), is starting his lecture on urothelial markers in ten minutes! Hurry on over to Venetian C. #AUA25

Congrats to @bbmdmsk on an amazing career summarized in his Whitmore lecture. @UroOnc #AUA2025

Resident Physician, Nicole Handa, MD (@nicole_handa), presenting work on PI-RADS scores in Black men at the health equity forum. This was one of the top rated abstracts by blinded review at the #AUA25! 👏

Engaging case-based session at #AUA25 reviewing 2025 updates to the microhematuria guidelines. Expert commentary from @SBoorjian @TMDownsmd @DrMBWesterman @DanBarocas. Addition of urine based biomarkers for intermediate risk MU https://t.co/davQkOimmO 🖊️ @EricLiUro takeover

At the #AUA25 Health Equity Forum, @nicole_handa presents a key secondary analysis from the PREVENT Trial: Risk of clinically significant prostate cancer in Black men with PIRADS 3 & 4 lesions. @NM_Urology @EdwardSchaeffer @DrAdamMurphy 🖊️ @EricLiUro takeover

🚨Next at #AUA25: Where do we stand with focal therapy for intermediate-risk prostate cancer? Pro: @LondonProstate1 @Lara__Rodriguez Con: @EdwardSchaeffer @HimanshuNagarMD 🖊️ @EricLiUro takeover

@EricLiUro will be taking over our account on Saturday, 4/26 during #AUA25. Throughout the day, Dr. Li will highlight key prostate cancer data, share session updates, photos with colleagues, and more. Don’t miss his insights. Stay tuned! @NM_Urology @NUFeinbergMed